Abstract:Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a major cause of stroke and morbidity. Recent genome-wide association studies have shown that paired-like homeodomain transcription factor 2 (Pitx2) to be strongly associated with AF. However, the mechanisms underlying Pitx2 modulated arrhythmogenesis and variable effectiveness of antiarrhythmic drugs (AADs) in patients in the presence or absence of impaired Pitx2 expression remain unclear. We have developed multi-scale computer models, ranging from a single cell to tissue level, to mimic control and Pitx2-knockout atria by incorporating recent experimental data on Pitx2-induced electrical and structural remodeling in humans, as well as the effects of AADs. The key findings of this study are twofold. We have demonstrated that shortened action potential duration, slow conduction and triggered activity occur due to electrical and structural remodelling under Pitx2 deficiency conditions. Notably, the elevated function of calcium transport ATPase increases sarcoplasmic reticulum Ca<sup>2+</sup> concentration, thereby enhancing susceptibility to triggered activity. Furthermore, heterogeneity is further elevated due to Pitx2 deficiency: 1) Electrical heterogeneity between left and right atria increases; and 2) Increased fibrosis and decreased cell-cell coupling due to structural remodelling slow electrical propagation and provide obstacles to attract re-entry, facilitating the initiation of re-entrant circuits. Secondly, our study suggests that flecainide has antiarrhythmic effects on AF due to impaired Pitx2 by preventing spontaneous calcium release and increasing wavelength. Furthermore, our study suggests that Na<sup>+</sup> channel effects alone are insufficient to explain the efficacy of flecainide. Our study may provide the mechanisms underlying Pitx2-induced AF and possible explanation behind the AAD effects of flecainide in patients with Pitx2 deficiency.Atrial fibrillation (AF) is an abnormal heart rhythm that can lead to stroke and death. Recent studies have uncovered that AF-associated risk variants are adjacent to the Pitx2 locus, furthermore, the have demonstrated that AF patients with these variants respond better to certain antiarrhythmic drugs (AADs). However, the mechanisms underlying Pitx2 modulated arrhythmogenesis and variable effectiveness of AADs remain unclear. To untangle this issue, we have developed multi-scale computer models, ranging from single cell to tissue level, to mimic control and the Pitx2-knockout atria by incorporating experimental data on Pitx2-induced electrical and structural remodelling, as well as the effects of class I ADDs (flecainide). We discovered that removal of Pitx2 caused AF characterized by focal beats and re-entrant waves. It was found that these abnormalities can be attributed to triggered beats, action potential duration shortening and slow conduction arising from Pitx2-induced remodelling. Interestingly, these Pitx2-induced AF can be suppressed in the presence of class I AADs such as flecainide. Our simulations revealed that flecainide prevents triggered beats by blocking the function of ryanodine receptors and that flecainide can terminate re-entrant waves by prolonging action potential duration due to its actions on potassium channels.

Underlying Mechanism of Atrial Fibrillation-Associated Nppa-I137T Mutation and Cardiac Effect of Potential Drug Therapy

Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation

Mutation in NPPA Causes Atrial Fibrillation by Activating Inflammation and Cardiac Fibrosis in a Knock‐in Rat Model

Neuronal Nav1.8 Channels As a Novel Therapeutic Target of Acute Atrial Fibrillation Prevention.

Cold-inducible RNA-binding Protein Modulates Atrial Fibrillation Onset by Targeting Multiple Ion Channels.

SNX17 (sorting Nexin 17) Mediates Atrial Fibrillation Onset Through Endocytic Trafficking of the Kv1.5 (potassium Voltage-Gated Channel Subfamily A Member 5) Channel

Effects of Phenylacetylglutamine on the Susceptibility of Atrial Fibrillation in Overpressure-Induced HF Mice

Molecular Mechanisms Underlying Ionic Remodeling in a Dog Model of Atrial Fibrillation

Identification of NPPA Variants Associated with Atrial Fibrillation in a Chinese GeneID Population.

Inhibition of late sodium current via PI3K/Akt signaling prevents cellular remodeling in tachypacing-induced HL-1 atrial myocytes

Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC–derived atrial fibrillation model

Interactions Between Metabolism Regulator Adiponectin and Intrinsic Cardiac Autonomic Nervous System: A Potential Treatment Target for Atrial Fibrillation

Atrial Fibrillation and Electrophysiology in Transgenic Mice with Cardiac-Restricted Overexpression of FKBP12.

Ultrasound-mediated Piezoelectric Nanoparticle Modulation of Intrinsic Cardiac Autonomic Nervous System for Rate Control in Atrial Fibrillation

In silico investigation of the mechanisms underlying atrial fibrillation due to impaired Pitx2

Effects of Angiotensin Receptor-Neprilysin Inhibitor in Arrhythmogenicity Following Left Atrial Appendage Closure in an Animal Model

Molecular and Functional Relevance of NaV1.8-Induced Atrial Arrhythmogenic Triggers in a Human SCN10A Knock-Out Stem Cell Model

Targeting myocardial inflammation: investigating the therapeutic potential of atrial natriuretic peptide in atrial fibrosis

Regulation of the NRG1/ErbB4 Pathway in the Intrinsic Cardiac Nervous System is a Potential Treatment for Atrial Fibrillation.

Further insights into the underlying electrophysiological mechanisms for reduction of atrial fibrillation by ranolazine in an experimental model of chronic heart failure

PPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation